Table 4.
Variable | univariate analysis | multivariate analysis | |||
---|---|---|---|---|---|
OR (95%) | p-value | OR (95%) | p-value | ||
Diabetes | Age | 1.018 (0.974–1.065) | 0.431 | 1.014 (0.966–0.966) | 0.574 |
Alcohol drinking (vs non) | 0.644 (0.164–2.183) | 0.495 | 0.944 (0.178–4.66) | 0.944 | |
Cigarette smoking (vs non) | 0.636 (0.187–1.929) | 0.439 | 0.436 (0.093–1.113) | 0.267 | |
Coronary artery lesions (vs single-vessel disease) | 1.095 (0.680–1.767) | 0.709 | 1.068 (0.626–1.818) | 0.808 | |
ALDH2 *2 carriers vs ALDH2 *1 homozygotes | 3.667 (1.606–8.727) | 0.002 | 4.053 (1.668–10.449) | 0.003 | |
Clopidogrel | 1.472 (0.551–4.221) | 0.451 | 0.899 (0.297–2.829) | 0.851 | |
Statins | 1.500 (0.140–32.83) | 0.743 | 1.817 (0.145–2.794) | 0.651 | |
ACEI/ARB | 1.376 (0.654–2.914) | 0.400 | 1.205 (0.528–2.748) | 0.656 | |
Non-diabetes | Age | 1.015 (0.995–1.037) | 0.145 | 1.009 (0.987–1.031) | 0.424 |
Alcohol drinking (vs non) | 0.868 (0.508–1.445) | 0.591 | 1.177 (0.581–2.374) | 0.649 | |
Cigarette smoking (vs non) | 0.801 (0.505–1.253) | 0.337 | 0.694 (0.379–1.241) | 0.225 | |
Coronary artery lesions (vs single-vessel disease) | 1.746 (1.355–2.261) | < 0.001 | 1.677 (1.284–2.200) | < 0.001 | |
ALDH2 *2 carriers vs ALDH2 *1 homozygotes | 1.191 (0.766–1.841) | 0.433 | 1.112 (0.693–1.774) | 0.657 | |
Clopidogrel | 1.918 (1.129–3.382) | 0.019 | 1.857 (1.073–3.329) | 0.031 | |
Statins | 3.333 (1.117–14.329) | 0.055 | 2.594 (0.839–11.376) | 0.138 | |
ACEI/ARB | 1.210 (0.785–1.855) | 0.385 | 1.008 (0.635–1.586) | 0.974 |
Note: This statistical analysis was performed by R statistical software version 3.3.3. ACEI Angiotensin-Converting Enzyme Inhibitors, ARB Angiotensin Receptor Blocker